Adenovirus or naked plasmid DNA (pDNA) has been used to deliver the therapeutic gene into corpus cavernosum. However, the potential risks of viral vector and inefficiency of naked pDNA have limited their clinical application. In this study, water-soluble lipopolymer (WSLP) was evaluated as a gene carrier to corpus cavernosum. The WSLP/pDNA complex was transfected to smooth muscle cells in vitro. WSLP had high transfection efficiency, which was comparable to poly(ethylenimine) (PEI). In addition, WSLP had much less cytotoxicity than PEI, suggesting that WSLP is a safer carrier than PEI. To evaluate the transfection efficiency to corpus cavernosum, the WSLP/pDNA complex was injected into the rat corpus cavernosum. As a result, the WSLP/pDNA complex showed higher transfection efficiency than naked pDNA. In addition, the gene expression was dependent upon the dose of the complex. The results suggest that WSLP may be useful for gene therapy of erectile dysfunction.
Introduction
Gene therapy is a method to introduce genetic materials into cells to produce therapeutic effect. The gene therapy methods have been developed to treat various inherited or acquired diseases such as hemophilia, cancer, and cardiovascular diseases. Many clinical gene therapy trials have been reported and some of them showed successful results. 1 Gene delivery vehicles include viral vectors and nonviral vectors. Currently, viral vectors are the most efficient tool for gene delivery into live cells. 2 However, the potential risks of the viral vectors such as endogenous virus recombinations, oncogenic effects, and immunological reactions have limited the application of the viral vectors to clinical settings. [3] [4] [5] On the contrary, nonviral vectors showed better safety profile, although the gene delivery efficiency of these vectors is lower than that of viral vectors. 6 Nonviral vectors include liposomes, polymers, and naked DNA. Polymeric vectors showed many advantages as gene carriers such as low immunogenecity, low cytotoxicity, reproducibility, and low cost. 7 Gene therapy for erectile dysfunction (ED) has been developed using various therapeutic genes. Nitric oxide synthases (NOSs) have been extensively studied using adenoviral vector or naked plasmid DNA (pDNA) injection method. [8] [9] [10] [11] [12] [13] [14] The functional improvement after gene delivery suggests that gene therapy approaches will be able to eventually treat ED. The selection of an efficient therapeutic gene is one of the important considerations for the success of these gene therapy trials. To date, several genes have been evaluated as a therapeutic gene for the treatment of ED. They include endothelial NOS (eNOS), 8, 9, 12, 14 neuronal NOS (nNOS), 11 inducible NOS (iNOS), 10, 13 calcitonin gene-related peptide (CGRP), 15 vascular endothelial growth factor (VEGF), [16] [17] [18] brain-derived neurotrophic factor (BDNF), 17 and hSlo calcium-sensitive K channel. 19, 20 Another consideration is gene delivery carrier. For gene therapy of ED, adenovirus or naked pDNA has been widely used. However, it is generally accepted that adenovirus has high immunogenecity and, therefore, the application of the viral vector to clinical settings is limited. Naked DNA is safe in terms of cytoxicity and immunogenecitiy, but its low efficiency of gene transfer limits the gene therapy application. Therefore, development of a new gene delivery carrier is required for success of ED gene therapy. In this study, we evaluated water-soluble lipopolymer (WSLP) as a polymeric gene carrier to corpus cavernosum. WSLP was synthesized by the conjugation of cholesterol to low molecular weight poly(ethylenimine) (PEI1800, 1.8 kDa). High molecular weight PEI (PEI25000, 25 kDa) has been widely used in many polymeric gene delivery studies, because of its high gene transfer efficiency due to the proton sponge effect. 21, 22 However, PEI25000 also has high cytotoxicity.
23 PEI1800, on the contrary, has low cytotoxicity, but its gene transfer efficiency is much lower than that of PEI25000. 24, 25 However, the conjugation of cholesterol to PEI1800 increased the transfection efficiency, which was comparable to that of PEI25000. [24] [25] [26] [27] Furthermore, WSLP has low cytotoxicity. [24] [25] [26] WSLP has high transfection efficiency to A7R5 smooth muscle cells, mouse insulinoma MIN6 cells, CT-26 colon cancer cells in vitro. [24] [25] [26] [27] Corpus cavernosum has high smooth muscle cell content, and therefore, the high transfection efficiency of WSLP to smooth muscle cells suggests its usefulness for gene delivery to corpus cavernosum. In this research, we evaluated WSLP as a gene carrier to corpus cavernosum and the gene delivery condition was optimized.
Materials and methods

Synthesis of WSLP
WSLP was synthesized as described previously. 24 Briefly, PEI1800 was stirred on ice in a mixture of anhydrous methylene chloride and triethylamine for 30 min. Cholesteryl chloroformate was dissolved in methylene chloride and slowly added to the PEI solution. The mixture was stirred for 12 h on ice and the resulting product was dried on a rotary evaporator. The powder was dissolved in 0.1 N HCl. The aqueous solution was extracted with methylene chloride, and then filtered through a glass microfiber filter. The product was concentrated by solvent evaporation, precipitated with large excess acetone, and dried under a vacuum.
Culture of human corpus cavernosum smooth muscle cells
Tissue samples of corpus cavernosum were obtained from a 33-year-old otherwise healthy subject, who underwent coporoplasty for congenital penile curvature. Since corpus cavernosum biopsy is not part of the intervention, which relies on the reconstruction of tunica albuginea, the patient gave his informed consent according to the Helsinki Declaration of 1975, as revised in 1983, after being reassured that erectile tissue excision would be so small as to avoid any risk of ED. Primary cultures of human penile corpus cavernosum smooth muscle cells were established by seeding tissue explants in six-well plates (Falcon Co., Becton Dickenson, Franklin Lakes, NJ, USA) with Dulbecco's minimum essential medium (DMEM) supplemented with 10% fetal bovine serum (FBS), penicillin, streptomycin, and nystatin, as previously described. 28 Cells were propagated in 75 cm 2 flasks (Costar, Cambridge, MA, USA) and used at early passage (P1-P3) for all experiments.
In vitro transfection
A7R5 cells, a smooth muscle cell line, and human corpus cavernosum smooth muscle cells were maintained in DMEM medium supplemented with 10% FBS in a 5% CO 2 incubator. For the transfection studies, the cells were seeded at a density of 2.5 Â 10 5 cells/well in six-well plates 24 h before transfection. After 24 h, the cells were washed twice with serum-free DMEM medium, and then 2 ml of fresh serum-free medium was added. The WSLP/ pCMV-Luc or WSLP/pCMV-GFP complex was prepared at a 40:1 N:P (nitrogen atom of polymer:phosphate of pDNA) ratio according to the previous report. 25 The PEI25000/pDNA complex was prepared at a 5:1 N:P ratio based on the previous reports. 21, [29] [30] [31] [32] The polymer/pDNA complexes were added to the cells. The amount of pDNA was fixed at 2 mg/well. The cells were then incubated for 4 h at 371C in a 5% CO 2 incubator. After 4 h, the transfection mixtures were removed and 2 ml of fresh DMEM medium containing FBS was added. The cells were incubated for an additional 20 or 44 h at 371C.
Luciferase assay and fluorescence microscopy
After transfection, the cells were washed with PBS, and 150 ml of reporter lysis buffer (Promega, Madison, WI, USA) was added to each well. After 15 min of incubation at room temperature, the cells were harvested and transferred to microcentrifuge tubes. After 15 s of vortexing, the cells were centrifuged at 11k r.p.m. for 3 min. The extracts were transferred to fresh tubes. The protein concentrations of the extracts were determined by using BCA protein assay kit (Pierce, Iselin, NJ, USA). Luciferase activity was measured in terms of relative light units (RLU) using a 96-well plate Luminometer (Dynex Technologies Inc., Chantilly, USA). The final values of Plasmid delivery to corpus cavernosum M Lee et al luciferase were reported in terms of RLU/mg total protein.
The pCMV-GFP transfected cells were examined by fluorescence microscopy (Nikol Eclipse, Biorad Co., CA, USA) at a magnification of Â 40 after transfection. Under the same magnification, all images were exposed using the same exposure time.
Cytotoxicity assay
Evaluation of cytotoxicity was performed by the 3-(4,5-dimetylthiazol)-2,5-diphenyltetrazolium bromide (MTT) assay.
33 A7R5 cells were seeded at a density of 2 Â 10 4 cells/well in 96-well microassay plates (Falcon Co., Becton Dickenson, Franklin Lakes, NJ, USA), and incubated for 24 h before transfection. The WSLP/pDNA complex was prepared at a 40:1 N:P ratio and PEI25000/pDNA complex was prepared at a 5:1 N:P ratio. The amount of pDNA was fixed at 0.2 mg/well. Polymer/ pDNA was added to the cells and incubated for 4 h at 371C. After the incubation, the transfection mixture was replaced with 100 ml of fresh DMEM medium supplemented with 10% FBS. The cells were incubated for an additional 20 h at 371C. After the incubation, 24 ml of 2 mg/ml MTT solution in PBS was added. The cells were incubated for an additional 4 h at 371C and then MTT-containing medium was aspirated off and 150 ml of DMSO was added to dissolve the formazan crystal formed by live cells. Absorbance was measured at 570 nm. The cell viability (%) was calculated according to the following equation:
Cell viability ð%Þ¼ðOD 570ðsampleÞ =OD 570ðcontrolÞ ÞÂ100
where the OD 570(sample) represents the measurement from the wells treated with polymer/pDNA complex and the OD 570(control) represents the measurements from the wells treated with 5% glucose solution only.
In vivo administration of the WSLP/pDNA complex into corpus cavernosum
Adult male Sprague-Dawley rats weighing 300-350 mg were used for all animal experiments. The rats were maintained in standard cages under clean conditions in separate quarters in a 12:12 h lightdark cycle with free access to water and pellets. The experiments performed were approved by the Institutional Animal Care and Use Subcommittee of our university. The rats were anesthetized with chloral hydrate (20 mg/kg) intraperitoneally and placed on a thermoregulated surgical table. Using sterile technique, penile skin was incised and tunica albuginea was exposed. To optimize the N:P ratio of the complex, the WSLP/pCMV-Luc complex was formulated at a 5:1, 10:1, 20:1, or 40:1 N:P ratio. Using a 28 G disposable syringe, 100 ml of each complex (n ¼ 6) was injected into the mid portion of corpus cavernosum and the needle was left in place for 2 min to allow the gene to diffuse throughout the cavernous space. Immediately before the injection, Plasmid delivery to corpus cavernosum M Lee et al blood drainage via the dorsal veins was halted by circumferential compression of the penis at the base with an elastic band and compression was released at the desired time after the injection because genes are liable to systemic circulation due to the vascular nature of corpus cavernosum. The incision was closed with 6-0 vicryl sutures. At 2 days after injection, the penis was harvested and the transgene expression was measured by luciferase assay. Based on this result, transfection efficiency of the WSLP/ pCMV-Luc complex (20:1 N:P ratio) was compared with the group injected with naked DNA or the PEI25000/pCMV-Luc complex (5:1 N:P ratio) at day 2 (n ¼ 6). We also evaluated the effect of different DNA doses (2.5, 5, or 10 mg; n ¼ 6) and duration of penile base compression (0, 5, 10, 20, 30 min; n ¼ 4) on the transfection efficiency at 2 days after injection of the WSLP/pCMV-Luc complex (20:1 N:P ratio).
Fluorescence microscopy of GFP in corpus cavernosum
The rats were injected with pCMV-GFP or WSLP/ pCMV-GFP (20:1 N:P ratio) or PEI25000/pCMV-GFP complex (5:1 N:P ratio, n ¼ 4) intracavernously. To identify the cells expressing the transferred gene, we examined the resected specimen and frozen section of corpus cavernosum by fluorescence microscopy (Nikol Eclipse, Biorad Co., CA, USA) at 2 days after intracavernous injection. Serial sections (8 mm) were cut with a cryostat and placed on slide glasses. Under the same magnification, all images were exposed using the same exposure time. For estimation of the transfection efficacy, GFP-positive areas were analyzed using Scion Image software version 4.02 (Scion Co., MD, USA). For each slide, we randomly selected five areas using a fluorescence microscope at a magnification of Â 200. The GFPpositive area was expressed as a percentage of the total area [(GFP positive area/total area) Â 100].
Results
Transfection and cytotoxicity of WSLP to smooth muscle cells
The WSLP/pCMV-Luc, PEI25000/pCMV-Luc complexes, and naked pCMV-Luc were transfected to Plasmid delivery to corpus cavernosum M Lee et al A7R5 cells and the expression level of transgene was measured by luciferase assay. The transfection efficiency of WSLP was comparable to that of PEI25000 and much higher than that of naked pCMV-Luc (Figure 1a ). This result confirmed the previous report. 25 The cytotoxicity of WSLP was also evaluated by MTT assay. WSLP/pCMV-Luc complex, PEI25000/ pCMV-Luc complex, and naked pCMV-Luc were transfected and the cell viability was measured. As a result, naked plasmid did not show any cytotoxicity and WSLP has much less cytotoxicity compared with PEI (Figure 1b) . This result confirmed the previous results, suggesting that WSLP is safer than PEI for gene delivery. 25 To evaluate the transfection efficiency of WSLP to human corpus cavernosum smooth muscle cells, the WSLP/pCMV-GFP, PEI25000/pCMV-GFP complexes, and naked pCMV-GFP were transfected to primary corpus cavernosum smooth muscle cells. The GFP expression was examined by fluorescence microscopy. As a result, the transfection efficiency of WSLP was comparable to that of PEI25000 ( Figure  2a and b) . In the cells transfected with naked pCMV-GFP, the GFP expression was not detected.
N:P ratio-dependent transfection efficiency to corpus cavernosum
The highest transgene expression was obtained at a 20:1 N:P ratio (Figure 3) . At a 20:1 N:P ratio, the WSLP/pCMV-Luc complex was compared with naked DNA and the PEI25000/pCMV-Luc complex in terms of transfection efficiency. The PEI25000/ pCMV-Luc and WSLP/pCMV-Luc complexes were prepared at a 5:1 N:P ratio and 20:1 N:P ratio, respectively. At 2 days after the injection, the tissues were harvested and the transgene expression was measured by luciferase assay. As a result, the WSLP and PEI showed much higher gene transfer efficiency than naked DNA (Figure 4 ). This result was confirmed by delivery of pCMV-GFP. The PEI25000/ pCMV-GFP, WSLP/pCMV-GFP complexes and naked pCMV-GFP were injected to corpus cavernosum. The tissues were examined by fluorescence microscopy 2 days after the injection. The results showed that WSLP and PEI had higher transfection efficiency than naked DNA in corpus cavernosum (Figure 5a and b) . Figure 4 Transfection efficiency of WSLP, PEI25000, and naked pDNA to corpus cavernosum. WSLP/pCMV-Luc complex was prepared at a 20:1 N:P ratio. PEI25000/pCMV-Luc complexes were formulated at a 5:1 N:P ratio. WSLP/pCMV-Luc, PEI25000/pCMVLuc complex, or naked pDNA was injected to corpus cavernosum of SD rats. Transgene expression was evaluated 2 days after the injection by luciferase assay. The data are expressed as mean values (7standard error) of six experiments. *Po0.01 as compared with naked pDNA, but no statistical significance as compared with PEI25000. 
Dose and ligation time-dependent gene expression
To evaluate dose-dependent transfection, the WSLP/ pCMV-Luc complex was injected at a DNA dose of 2.5, 5, or 10 mg. As a result, the luciferase expression was the highest in the tissue injected with the highest dose ( Figure 6 ). The results suggest that the transfection is dependent on the dose of injection. Another important point is ligation time. At the time of injection, the WSLP/DNA complex might be leaked into the systemic circulation, because of the vascular nature of corpus cavernosum. Therefore, increasing the ligation time, in which the complex was maintained in the tissue, might increase the overall transfection efficiency. Based on this hypothesis, we ligated the penile base immediately before injection with an elastic band and it was placed for the indicated time after the injection. As expected, the gene expression level was increased with the ligation time ( Figure 7) . Therefore, this result suggests that the ligation time is an important factor to increase the gene transfer into corpus cavernosum.
Discussion
We have shown that polymeric gene carrier, WSLP, delivered a reporter gene to corpus cavernosum efficiently. The gene delivery efficiency of WSLP was comparable to that of PEI. However, considering the cytotoxicity of PEI, which was shown in Figure 1b , WSLP may be a more suitable polymeric gene carrier to corpus cavernosum than PEI.
It has been proved that ED can be treated by gene therapy using therapeutic genes such as NOS, VEGF, and hSlo. [8] [9] [10] [11] [12] [13] [14] [17] [18] [19] [20] To date, gene delivery to corpus cavernosum was performed using adenovirus or naked plasmid. However, due to the intrinsic property of adenoviral vector and inefficiency of naked pDNA, safer and more efficient vector is required for gene therapy of ED. Polymeric gene carriers have been developed as an alternative for viral gene delivery vectors in many gene delivery researches. Owing to the excellent characteristics such as low cytotoxicity, low immunogenecity, no integration into host chromosome, and reproducibility, polymeric carriers have been intensively studied for gene delivery to various organs. Therefore, polymeric gene carriers may be applicable for gene therapy of ED. Based on this hypothesis, we evaluated WSLP as a gene carrier to corpus cavernosum. WSLP has excellent characteristics as a gene carrier. WSLP has a high transfection efficiency and low cytotoxicity to smooth muscle cells (Figures 1a, b and 2) . In vivo administration showed that WSLP had highest gene delivery efficiency to corpus cavernosum at a 20:1 N:P ratio (Figure 3) . The previous report of gene delivery to the myocardium using WSLP showed that WSLP had the highest transfection efficiency at a 10:1 N:P ratio. 25 These results suggest that the optimal N:P ratio may be dependent on the tissue type. At a 20:1 Plasmid delivery to corpus cavernosum M Lee et al N:P ratio, WSLP had the transfection efficiency that was comparable to PEI25000. PEI25000 has been reported to have high transfection efficiency to various cells in vitro. In addition, PEI25000 has been used to deliver therapeutic genes systemically or locally in vivo. However, PEI has high toxicity and it is not applicable to clinical settings. As proved in this research, PEI25000 had higher cytotoxicity to A7R5 cells than WSLP. However, WSLP had negligible toxicity to A7R5 cells, which was much lower than PEI25000. WSLP is composed of PEI1800 and cholesterol. WSLP has the characteristics of PEI1800 in cytotoxicity, and the characteristics of PEI25000 in transfection efficiency. As proved in the previous report, WSLP has substantial proton buffering effect, which facilitates the endosomal escape. 25 In addition, the WSLP/pDNA complex is internalized into the cells using cholesterol uptake pathway via LDL receptor. It was suggested that WSLP has high transfection efficiency due to the LDL receptormediated endocytosis pathway. 25 Another factor that increases the gene transfection efficiency is the localization period of the delivered gene. In the case of local injection to corpus cavernosum, it is possible that the injected WSLP/pDNA complex is leaked into the systemic circulation due to the vascular nature of the tissue. However, the ligation of the penile base increased the localization period of the complex in the tissue and enhanced the transfection efficiency. The ligation of 30 min was more effective than shorter ligation time ( Figure 7) .
In summary, WSLP has high transfection efficiency to smooth muscle cells in vitro and cavernosum in vivo. Furthermore, the cytotoxicity of WSLP to smooth muscle cells was negligible. All of these results suggest that WSLP is an efficient and safe gene carrier to corpus cavernosum.
